Viewing Study NCT04234061

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 12:05 PM
Ignite Modification Date: 2026-01-29 @ 12:48 PM
Study NCT ID: NCT04234061
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-07
First Post: 2020-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Clinical Trial to Assess The Efficacy and Safety of the Combination of Tisagenlecleucel And Ibrutinib in Mantle Cell Lymphoma
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Mantle Cell Lymphoma Recurrent View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ibrutinib View
None Tisagenlecleucel View
None Chimeric Antigen Receptor - Tcell (CAR-T) View
None B-cell non-Hodgkin lymphoma View
None TP53 mutation View
None bruton's tyrosine kinase (BTK) inhibitor View